Connect with us


Cannabidiol Oil (CBD Oil) Market Report Expected Massive Growth by 2020-2026 | Absolute Terps …

Republished by Plato



New Jersey, United States,- The Cannabidiol Oil (CBD Oil) Market is predicted by Market Research Intellect’s report to find players focusing on new product development to secure a strong position in terms of revenue sharing. Strategic collaboration can be a powerful way to bring new products to the market. The level of competition observed in the market may increase.

This research report categorizes the global market by players/brands, regions, types, and applications. The report also analyzes the global market status, competitive landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, five forces of distributors, and porters.

The latest 2020 edition of this report reserves the right to provide further comments on the latest scenarios, recession, and impact of COVID-19 on the entire industry. It also provides qualitative information on when the industry can rethink the goals the industry is taking to address the situation and possible actions.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

  • Absolute Terps
  • Kazmira
  • The Lab
  • CW Hemp/ CW Botanicals
  • Freedom Leaf
  • Whistler
  • Green Road
  • Emblem Cannabis Oils
  • Medical Marijuana
  • Aphira
  • Folium Biosciences
  • Canopy Growth Corporation
  • HempLife Today
  • K.I.N.D. Concentrates
  • Cannavest
  • and Pharmahemp.

    Cannabidiol Oil (CBD Oil) Market Segment Analysis-

    The research report includes specific segments by Type and Application. Each type provides information about the production during the forecast period of 2015 to 2026. The application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid market growth.

    In market segmentation by types of Drug Cabinets, the report covers-

  • Hemp-derived Type
  • Marijuana-derived Type

    In market segmentation by applications of the Drug Cabinets, the report covers the following uses-

  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other

    The study analyses the following key business aspects:

    Analysis on Strategies of Leading Players: Market players can use this analysis to gain competitive advantage over their competitors in the Cannabidiol Oil (CBD Oil) market.

    Study on Key Market Trends: This section of the report offers a deeper analysis of the latest and future trends of the Cannabidiol Oil (CBD Oil) market.

    Market Forecasts: Buyers of the report will have access to accurate and validated estimates of the total market size in terms of value and volume. The report also provides consumption, production, sales, and other forecasts for the Cannabidiol Oil (CBD Oil) market.

    Regional Growth Analysis: All major regions and countries have been covered in the report. The regional analysis will help market players to tap into unexplored regional markets, prepare specific strategies for target regions, and compare the growth of all regional markets.

    Segmental Analysis: The report provides accurate and reliable forecasts of the market share of important segments of the Cannabidiol Oil (CBD Oil) market. Market participants can use this analysis to make strategic investments in key growth pockets of the Cannabidiol Oil (CBD Oil) market.

    Business Opportunities in Following Regions and Countries:

    ➮ North America (United States, Canada, and Mexico)

    ➮ Europe (Germany, UK, France, Italy, Russia, Spain, and Benelux)

    ➮ Asia Pacific (China, Japan, India, Southeast Asia, and Australia)

    ➮ Latin America (Brazil, Argentina, and Colombia)

    How will the report assist your business to grow?

    ➮ The document offers statistical data about the value (US $) and size (units) for the Cannabidiol Oil (CBD Oil) industry between 2020 to 2026.

    ➮ The report also traces the leading market rivals that will create and influence the Cannabidiol Oil (CBD Oil) business to a greater extent.

    ➮ Extensive understanding of the fundamental trends impacting each sector, although greatest threat, latest technologies, and opportunities that could build the global Cannabidiol Oil (CBD Oil) market both supply and offer.

    ➮ The report helps the customer to determine the substantial results of major market players or rulers of the Cannabidiol Oil (CBD Oil) sector.

    Reason to Buy this Report:

    Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global Cannabidiol Oil (CBD Oil) Market. Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends in Cannabidiol Oil (CBD Oil) Market, thereby allowing players to develop effective long term strategies.

    About Us:

    Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

    Contact Us:

    Mr. Steven Fernandes

    Market Research Intellect

    New Jersey ( USA )

    Tel: +1-650-781-4080

  • Source:


    Dosage for CBG/CBD tincture from LN?

    Republished by Plato



    I just ordered the 1:1 CBG/CBD tincture from L. Naturals since I’ve heard CBG does wonders to anxiety, but since I am taking CBD now I didn’t want to go “cold turkey” off CBD and switch to CBG isolate (without knowing how well CBG works, plus full-spectrum/entourage effect).

    Right now I am taking 25mg three times a day (1.25ml or 0.50ml three times of the high-potency tincture). What should I start with? I know really I should start low and increase, but like I said I don’t want to quit taking CBD while doing this process even though I know I should be good for a couple of days not taking my daily doses. Also, I’m on a lot of prescriptions right now that aren’t being affected, or noticeably affected, by CBD. Will CBG differ, especially with benzos/SSRI’s?


    Continue Reading


    Indus Holdings, Inc. Welcomes Bruce Gates to Board of Directors; Announces Results of Annual Shareholder Meeting

    California cannabis industry leader adds veteran executive and strategic advisor to leadership team SALINAS, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF), a leading, vertically-integrated cannabis company (the “Company”), is pleased to announce that at its annual shareholder meeting held on October 22, 2020 (the “Meeting”) shareholders voted in […]

    Republished by Plato



    California cannabis industry leader adds veteran executive and strategic advisor to leadership team

    SALINAS, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF), a leading, vertically-integrated cannabis company (the “Company”), is pleased to announce that at its annual shareholder meeting held on October 22, 2020 (the “Meeting”) shareholders voted in excess of 99% in favour of election of the Company’s nominees to the Board of Directors and the appointment of the Company’s auditors. At the Meeting, shareholders elected each of the incumbent directors of the Company nominated, in addition to new Company nominee Bruce A. Gates, a veteran executive and strategic advisor.

    Mr. Gates serves as the Founder and President of Three Oaks Strategies LLC, a Virginia-based consulting firm that advises companies and individuals on strategic communications matters and public policy. He is also Founder and President of Three Oaks Asset Management LLC, a family office and venture capital firm that works to augment its financial participation with management advice, marketing advice, and relationship-building advice.

    Bruce Gates is a seasoned executive with immense experience within complex regulatory environments set against shifting political backdrops.

    Indus Holdings, Inc. Chairman of the Board George Allen

    We are incredibly fortunate to have a leader and strategist of Bruce’s caliber on our board as we work to continue to take Indus to new heights of success.

    Mr. Gates has served as Senior Vice President of External Affairs for Altria and briefly served as Altria’s representative on the board of Chronos Inc. He was a founding partner of Washington, D.C. public policy advocacy firm Washington Council, which was acquired by Ernst & Young in 2000.

    “While it is still a young company, Indus has set the standard for a vertically-integrated cannabis operation with its acclaimed brand portfolio and commitment to being compliant in a highly regulated industry,” Mr. Gates says. “I am very grateful for the opportunity to lend my expertise to the board and I look forward to even greater success for Indus.”

    Mr. Gates’ election comes as Indus Holdings, Inc. Co-Founder Robert Weakley departs the Board of Directors.

    “We would like to thank Robert for all his service and his immense contributions to this Company as its co-founder. It is not easy for a founder to leave a company that he/she started and Rob has done an exemplary job and made every effort to make the transition as successful as possible. We are very grateful for Robert,” Mr. Allen says.

    With Mr. Gates’ election, the following individuals now serve on the Board of Directors: George Allen (Chairman), Mark Ainsworth (Chief Executive Officer), Stephanie Harkness, William Anton, Kevin McGrath, Brian Shure and Bruce Gates.

    In connection with the Meeting, the Company delivered a management information circular dated September 22, 2020 to its shareholders and filed the same on SEDAR. Prior to the filing thereof, the Company relied on the temporary blanket relief provided by the Canadian Securities Administrators, including the exemptive relief contained in Ontario Instrument 51-504 – Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials of the Ontario Securities Commission, to postpone the public filing of its executive compensation disclosure required under National Instrument 51-102 – Continuous Disclosure Obligations in respect of the Company’s financial year ended December 31, 2019.

    Indus Holdings, Inc. (CSE: INDS; OTCQX: INDXF) is a vertically-integrated cannabis company with advanced production capabilities, including cultivation, extraction, manufacturing, brand sales & marketing, and distribution. Founded in 2014 and based in Salinas, California, Indus offers services supporting every step of the supply chain and an extensive portfolio of award-winning brands, including Cypress Cannabis, House Weed, The Original Pot Co., MOON, Humble Flower, and Kaizen Medicinals. Indus Distribution, a division of Indus Holdings, Inc., is a leading California distributor of cannabis products, servicing an extensive portfolio of brands and licensed retailers.

    Original press release

    Published by NCV Newswire
    NCV Newswire
    The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

    Get Our Sunday Newsletter


    Continue Reading


    Leading Colorado Edibles Brand Sees This Product as The Future of Cannabis Consumption

    Exclusive Interview with 1906 Co-Founder and CEO Peter Barsoom Since launching in 2017, edibles company 1906 has been focused on creating a new product category: functional cannabis. It sees the opportunity to offer high-functioning adults an alternative to alcohol and pharmaceuticals as they navigate daily life, according to Co-Founder and CEO Peter Barsoom. Barsoom last […]

    Republished by Plato



    Exclusive Interview with 1906 Co-Founder and CEO Peter Barsoom

    Since launching in 2017, edibles company 1906 has been focused on creating a new product category: functional cannabis. It sees the opportunity to offer high-functioning adults an alternative to alcohol and pharmaceuticals as they navigate daily life, according to Co-Founder and CEO Peter Barsoom. Barsoom last spoke with New Cannabis Ventures in April 2019, and he checked in to discuss an innovative new product, new markets and continued expansion. The audio of the entire conversation is available at the end of this written summary.

    New Team Members

    Over the past year and a half, 1906 has made some additions to its leadership team. Jackie Cornell has taken on the role of Chief of Policy and Health Innovation. She has a long career in public health, previously working for the New Jersey Department of Health where she helped regulate the state’s medical market.

    Chonie Bradley joined 1906 as Vice President of Finance. She previously served as the Vice President of Finance with Anne Holland Ventures, the company behind MJBizCon.

    Market Reach and Expansion Philosophy

    1906 currently has a presence in Colorado and Oklahoma. Within the next couple of weeks, it will be launching into Illinois and Massachusetts as well.

    Inside 1906’s Operations (Photo Taken Prior to the COVID-19 Pandemic)

    The company is working toward becoming the top brand east of the Rockies, according to Barsoom. When considering potential markets, the 1906 team likes limited-license markets–medical, adult-use or about to become adult-use. States like Illinois, Massachusetts, Maryland, Pennsylvania and New Jersey are appealing. But, the company finds markets with low barriers to entry interesting as well. It has built success in markets like that with its Colorado and Oklahoma operations.

    1906 expects to be in four markets by the end of this year, and it plans to launch in three or four new markets next year.

    The company’s growth this year has had to take place during the COVID-19 pandemic, which has driven the company to embrace an agile and lean strategy. With such a capital-tight market, 1906 is approaching expansion into new markets with a capital-light mindset. It is reaching new markets through partnerships, but it is taking a unique approach.

    Instead of developing traditional licensing agreements, 1906 has created a mobile tableting operation. Through this initiative, a truck contains all the necessary equipment to create the company’s Drops. 1906 establishes a relationship with a local operator, taking up less than 750 square feet in their facility. Within just a few weeks, the operation can produce 3 to 5 million tablets of the 1906 Drops, according to Barsoom.

    The mobile tableting operations allow 1906 to expand into new markets with a consistent set of equipment and without a significant capital investment. It is able to retain ownership and control of its manufacturing processes and intellectual property. The company is able to capture 50 percent of wholesale revenue through its partnership deals, according to Barsoom.

    Product Portfolio

    1906 views its competition through a lens wider than just the cannabis industry. Products that people use to manage and enjoy their lives, whether it is a cup of coffee, a glass of wine or a sleep aid, are competition for 1906’s products.

    The company’s products, divided into different effects, are made with a combination of cannabinoids and other plant medicines. At the beginning of this year, 1906 launched its Genius effect, designed for cognitive focus. This product has a personal meaning for Barsoom. Diagnosed with ADD as a teenager, he has used Ritalin and Adderall for most of his adult life. While those medications worked for him, there are side effects. He hopes Genius can provide a potential alternative for cognitive focus. Already, Genius has become a top-selling product in Oklahoma, according to Barsoom.

    The Genius Effect Has Been Developed to Support Cognitive Focus.

    1906 has also launched its line of pressed tablets: Drops. These swallowable pills offer a way to experience cannabis in a traditional medicinal format. The Drops, available in any of 1906’s different effects, are controlled-dose, allergen-free and calorie-free. Barsoom sees this as becoming the future of cannabis consumption.

    The Development and Launch of 1906 Drops Has Been a Major Focus for the Company Over the Past Year.

    Previously, 1906 was excited about beverages, but now, the company has stepped back from this product category. Barsoom still sees opportunity in the long-term, but he thinks that social consumption will need to take off first.

    While beverages are on the backburner, 1906 has a robust innovation pipeline. The company is working on extended-release tablets for its Midnight effect. Sleep is a major issue for millions of people, and 1906 sees an underserved segment in that market: people who don’t have trouble falling asleep but struggle to stay asleep. This new product will target those people.

    1906’s Midnight Effect Features Chocolates Designed to Support Sleep. (Photo Taken Prior to the COVID-19 Pandemic)

    1906 is also developing products to address women’s health and different types of pain.

    Funding Insight

    1906 raised $18 million last fall, and now, the company is in the process of raising a bridge round. This senior secured debt note, which is mostly funded, will help provide the necessary capital to reach profitability, according to Barsoom. The company expects to hit this milestone by December. After that, funding will become driven more by opportunity.

    When allocating capital, 1906 carefully considers R&D projects as well as new market expansion.

    In terms of future capital opportunities, Barsoom is carefully watching the opportunities that are currently on the sidelines. The outcome of the 2020 election could mean an influx of new, large institutional players into the market. Additionally, Barsoom is watching to see how SPAC money will be chasing deals in the industry.

    Growth Outlook

    In its first month of operations in Oklahoma, 1906 exceeded revenue expectations by three to four times, and Barsoom expects this trend to continue. Once the company reaches profitability in December, he anticipates the company will generate significant operating cash flow. As the company moves forward, its team tracks important metrics like same-store sales, labor productivity and return on investment capital.

    While 1906 is highly focused on its innovation pipeline and expansion into new markets, the company is not losing sight of its responsibility to social justice. 1906 supports initiatives like the Last Prisoner Project and advocates for the creation of economic opportunities for people affected by the War on Drugs and for the end of mass incarceration. Barsoom sees the potential for cannabis to be a positive force in society, but he thinks the industry has not yet done enough to support and progress social justice issues.

    New Cannabis Ventures provides a customized landing page for 1906, which is a client of New Cannabis Ventures. Listen to the entire interview:

    Carrie Pallardy, a Chicago-based writer and editor, began her career covering the healthcare industry and now writes, edits and interviews subject matter experts across multiple industries. As a published writer, Carrie continues to tell compelling, undiscovered stories to her network of readers. For more information contact us.

    Get Our Sunday Newsletter


    Continue Reading
    Heartland2 days ago

    Web site credit card processing

    Heartland1 day ago

    CBG Study Shows Antimicrobial Properties of Cannabis

    Heartland1 day ago

    Medical Marijuana: 7 Incredible Health Benefits for Women

    Heartland5 days ago

    CBD Flower vs Vaping

    Heartland13 hours ago

    German Cannabis Flower Market is Ready to Explode

    Heartland5 days ago

    CBD weed in the U.K.

    Heartland4 days ago

    Best cbd oil uk

    Heartland5 days ago

    Giveaway for CBD Gummies on Instagram

    Heartland4 days ago

    Interesting effects from full spectrum

    Heartland4 days ago

    Awful taste – Lazarus Naturals. Is there flavored version better ?

    Heartland4 days ago

    Anyone else find Dosist pens wonky?

    Heartland4 days ago

    What type of hemp products do you use?

    Heartland4 days ago


    CBD3 days ago

    CBD and Geriatric Medicine: Should Seniors Take CBD?

    Heartland3 days ago

    CBG tinctures

    Heartland5 days ago

    Oof- CBD flower experience gone bad..

    Heartland5 days ago

    Has anyone ever tired any products from, “”? Wanting to try the CBD:CBG vape.

    Heartland4 days ago

    The Hemp Store Strategizes Wholesale Agreement With Maine Coast Hemp

    Heartland3 days ago

    Best CBD topical for Trigger Points?

    Heartland4 days ago

    Making cbd/cbg tinture

    Heartland4 days ago

    Review of several products from GreatCBDShop

    Heartland3 days ago

    CBD for anxiety/sleep

    CBD3 days ago

    CBD News: Hemp Industry Daily launches annual industry survey for business data

    Heartland3 days ago

    CBD & Cannabis for Endometriosis

    Heartland3 days ago

    Where do I start for depression?

    Heartland2 days ago

    Find your perfect sleep system

    Heartland1 day ago

    Thanks to these CBD “cigarettes” I am a full week tobacco/nicotine free 🎉

    Heartland9 hours ago

    Cybin Raises C$45 Million: The Largest Go Public Capital Raise in the Canadian Psychedelic Sector

    Heartland5 days ago

    Seven charged, 26 infringements issued during operation targeting anti-social behaviour …

    Heartland5 days ago

    First time vaping CBD for anxiety


    A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America